Townsend, R. R., Guarnieri, P., Argyropoulos, C., Blady, S., Boustany-Kari, C. M., Devalaraja-Narashimha, K., … TRIDENT Study Investigators, . (2020). Rationale and design of the Transformative Research in Diabetic Nephropathy (TRIDENT) Study. Kidney Int, 97(1), 10–13. https://doi.org/10.1016/j.kint.2019.09.020

Townsend, Raymond R., Paolo Guarnieri, Christos Argyropoulos, Shira Blady, Carine M. Boustany-Kari, Kishor Devalaraja-Narashimha, Lori Morton, et al. “Rationale and design of the Transformative Research in Diabetic Nephropathy (TRIDENT) Study.” Kidney Int 97, no. 1 (January 2020): 10–13. https://doi.org/10.1016/j.kint.2019.09.020.

Townsend RR, Guarnieri P, Argyropoulos C, Blady S, Boustany-Kari CM, Devalaraja-Narashimha K, et al. Rationale and design of the Transformative Research in Diabetic Nephropathy (TRIDENT) Study. Kidney Int. 2020 Jan;97(1):10–3.

Townsend, Raymond R., et al. “Rationale and design of the Transformative Research in Diabetic Nephropathy (TRIDENT) Study.” Kidney Int, vol. 97, no. 1, Jan. 2020, pp. 10–13. Pubmed, doi:10.1016/j.kint.2019.09.020.

Townsend RR, Guarnieri P, Argyropoulos C, Blady S, Boustany-Kari CM, Devalaraja-Narashimha K, Morton L, Mottl AK, Patel U, Palmer M, Ross MJ, Sarov-Blat L, Steinbugler K, Susztak K, TRIDENT Study Investigators. Rationale and design of the Transformative Research in Diabetic Nephropathy (TRIDENT) Study. Kidney Int. 2020 Jan;97(1):10–13.